Retension Pharmaceuticals, Inc. — Form D/A
Retension Pharmaceuticals, Inc. of MCLEAN, VA, a company, filed a Form D amendment with the SEC on 2024-05-15. The offering totals $11.0M, of which $10.1M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2024-05-15
- Form: D/A
- Accession: 0002002988-24-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $11.0M
- Amount sold: $10.1M
- Remaining: $856K
- Investors: 132
- Date of first sale: 2023-11-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-498860
Issuer
- Name: Retension Pharmaceuticals, Inc.
- CIK: 0002002988
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: C/O REDUX THERAPEUTICS, LLC, MCLEAN, VA, 22101
- Phone: (703) 624-2024
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Eric Keller | Director | McLean, VA |
| Eric Keller | Executive Officer | McLean, VA |
| Michael Berendt | Director | McLean, VA |
| Donald Olds | Director | McLean, VA |
Other filings by this issuer (2)
More